ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1472

Comparison Between Carotid Plaque and Carotid Intima-Media Thickness to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis

Lucia C. Domínguez-Casas1, Leyre Riancho-Zarrabeitia1, Nuria Vegas-Revenga2, Alfonso Corrales1, Carlos Fernández Díaz1, Montserrat Santos-Gómez3, Virginia Portilla2, Patrick H Dessein4, Ricardo Blanco1 and Miguel Angel Gonzalez-Gay1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 3Rheumatology, Hospital Can Misses, Ibiza, Spain, 4Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Cardiovascular disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   Carotid plaque (CP) detected by ultrasonography and carotid intima-media thickness (cIMT) are useful surrogate markers for subclinical atherosclerosis and good predictors of cardiovascular disease in the general population and rheumatoid arthritis (RA). Our aim was to determine if cIMT may predict the presence of carotid plaques.

Methods:   We evaluated 670 RA patients from Northern Spain without previous history cardiovascular events. Carotid ultrasonography was performed by a MyLab 70 scanner (Esaote; Genoa, Italy), equipped with 7-12 MHz linear transducer and the automated software guided technique radiofrequency–Quality Intima Media Thickness in real–time (QIMT, Esaote, Maastricht, Holland). The cIMT was determined as the average of three measurements in each common carotid artery. The final cIMT was the largest average cIMT (left or right). Carotid plaque was defined according to the Manheim Consensus Conference criteria. Based on studies reported in non-rheumatic patients, a cIMT was considered as associated with high cardiovascular risk if it was ≥ 0.90 mm.

Results:   Unilateral and bilateral carotid plaque frequency and cIMT values are summarized in the TABLE. cIMT values were 0.619±0.105 mm in patients without plaques and 0.774±0.161 mm in those with plaques (p<0.001). Using 0.90 mm as the cIMT cut-off value for high cardiovascular risk, the sensitivity to detect carotid plaques was 21.2% and the specificity 99%. A ROC curve comparing the presence of carotid plaque and cIMT was performed, being the area under the curve 0.795. The best cIMT cut-off point to determine the presence of plaques was considered as the one with the highest sensitivity and specificity. According to that, 0.670 mm was found to be the best cut-off point, being sensitivity and specificity for plaque detection 71.9% and 74% respectively. Positive predictive value for a cIMT ≥0.670 mm was 78.3% in our population, being 66.8% the negative predictive value. Regarding bilateral plaques, a cIMT cut-off value of 0.90 mm had sensitivity of 0.277 and specificity of 0.966. The ROC curve showed that the best cut-off point for bilateral plaque detection was also 0.670 mm with sensitivity 79.1% and specificity 64.2%.

Conclusion:   In Spanish RA patients cIMT ≥0.670 mm is a good predictor of carotid plaques. Our study suggests the possibility of considering a cIMT greater than 0.67 mm as a predictor of high cardiovascular risk in RA. TABLE

Variable
Carotid plaque, n (%) 379 (56.8)
Unilateral plaque, n (%) 128 (19.2)
Bilateral plaque, n (%) 251 (37.6)
cIMT (mean ±SD) mm 0.71± 0.16


Disclosure: L. C. Domínguez-Casas, None; L. Riancho-Zarrabeitia, None; N. Vegas-Revenga, None; A. Corrales, None; C. Fernández Díaz, None; M. Santos-Gómez, None; V. Portilla, None; P. H. Dessein, None; R. Blanco, None; M. A. Gonzalez-Gay, None.

To cite this abstract in AMA style:

Domínguez-Casas LC, Riancho-Zarrabeitia L, Vegas-Revenga N, Corrales A, Fernández Díaz C, Santos-Gómez M, Portilla V, Dessein PH, Blanco R, Gonzalez-Gay MA. Comparison Between Carotid Plaque and Carotid Intima-Media Thickness to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/comparison-between-carotid-plaque-and-carotid-intima-media-thickness-to-detect-subclinical-atherosclerosis-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-between-carotid-plaque-and-carotid-intima-media-thickness-to-detect-subclinical-atherosclerosis-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology